News

FAT jabs are better than widely prescribed metformin when it comes to curbing dementia risk in people with type 2 diabetes, ...
GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...
A recent study revealed that weight loss drugs, GLP-1s, including Ozempic and Zepbound, may help in treating several chronic ...
Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?
The study found Ozempic, ... The findings also suggest that treatment with semaglutide and similar drugs may be associated with a lower risk of dementia and can help reduce nicotine cravings.
A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health ...
THEY’VE been hailed as miracle weight-loss jabs – but the effects of Ozempic-style drugs could go far beyond the waistline. New research suggests these so-called “skinny pens” may also ...
A study released Monday of 200,000 people in the U.S. taking GLP-1s suggested the drugs' potential benefits extend beyond those currently recognized, such as a lower risk of Alzheimer's disease.
Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.
Blockbuster weight loss drugs like Ozempic, Wegovy and Mounjaro may slash the risk of a disorder affecting nearly 7million ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Researchers at Case Western Reserve University have discovered that the popular diabetes and weight-loss drug Ozempic may lower a person’s risk of developing dementia.. The active ingredient in ...